10th Latin Americal Conference on Clinical Research - São Paulo, October 20-22

Save the Date for LACCR 2013 in São Paulo Don’t miss the premier educational event in clinical research across Latin America – the 10th Latin American Conference on Clinical Research.   Engage in strategic discussion with global clinical researchers, industry and academia professionals on current clinical research policies and the fields’ role in the future of medicine at the event in São Paulo from October 20-22. The event is organized by the DIA in partnership with the Sociedade Brasileira de Medicina Farmaceutica (SBMF).   You will have the chance to update your knowledge and skills through state-of-the-art educational sessions and research presentations, and to exchange ideas and information with colleagues from Latin America and other countries.   Make sure you mark the date of the 10th Latin American Conference on Clinical Research in your calendar.  Read More     View PDF Featured Topics Regulatory update in clinical research Clinical research requirements for biosimilars Improving site competence in project management New approaches in orphan drugs/rare diseases Improvement of patient participation in clinical research Pharmacovigilance in clinical research Safety risk assessment in drug development Bioethics New business models to medicines development Comparative effectiveness research and health technology assessment  Read More     View PDF

IFPMA - Policies that Encourage Innovation in Middle-income Countries - report by Charles River Assoc

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) asked Charles River Associates (CRA) to investigate the conditions necessary to encourage innovation in middle-income countries. Ultimately, the purpose of this project is to evaluate the policies of host governments that encourage investment in innovative activities and the implications for future innovation policy.

The report focuses on eight case study countries (Brazil, China, Colombia, India, Malaysia, Russia, South Africa and South Korea). The case studies were chosen using a number of criteria. Firstly, we selected countries from different geographic regions, focusing on those that had been most successful in developing innovative activities to date in their region. Secondly, we chose countries that illustrate a range of different policy approaches. Thirdly, we chose a mix of countries with a long-standing objective of developing an innovative industry as well as countries that had only relatively recently embarked on this. Finally, we included South Korea as a basis of comparison, which was a middleincome country when it instigated its programme to encourage pharmaceutical innovation and provides a longer term perspective on what is achievable.

In addition, to reviewing the existing academic literature and government sources, we undertook 25 interviews with government officials, academics, industry trade associations and individual companies.

 

BIO Travels to Brazil to Support the Ecosystem of Innovation

from BIOtechNow by biotechnow@bio.org (Biotechnology Industry Organization)

 

Government policies that support innovation are critical as the biotechnology industry seeks to develop innovative healthcare, agricultural, industrial and environmental biotechnology products and provide them to people all around the world. Innovation requires not only scientific research and commercial expertise, but also supportive and dynamic governments that help facilitate long-term growth of the industry.

Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared biotechnology a national priority. Boosting biotech within Brazil has the potential to create high paying jobs and develop a healthier, more productive workforce.

This week BIO will be in Brazil for a roundtable meeting with representatives from Brazil’s National Committee on Biotechnology (or Comité Nacional de Biotecnologia (CNB)), representing close to a dozen relevant government agencies and ministries including the Ministry of Trade’s Innovation Secretariat, Ministry of Agriculture, Ministry of Health and Ministry of Science, Technology & Innovation.

for complete article: BIO Travels to Brazil to Support the Ecosystem of Innovation

Network and Learn with Peers at DIA’s Project Management Interactive Workshop - Sao Paulo, Brazil

Network and Learn with Peers at DIA’s Project Management Interactive Workshop DIA and SBMF are proud to announce our new tutorial on Project Management to be carried out  for the first time in Sao Paulo Brazil. Tutorial:  Project Management Training  Date of Program: November 5th - 7th, 2012 Location of Program: Travel Inn in São Paulo, Brazil Program Schedule: Day 1, 2 and 3 - DIA Project Management Training Professor: Joan Knutson, President,  PM, Guru Unlimited, San Francisco, CA, USA Continuing Education Credits: Name Credit Type Max Credits CEU Project Management IACET 18.50 1.9000 Project Management PMI 18.50 0.000  Read More DIA World Wide Executive Director Paul Pomerantz Advisory Council for Latin America Chair Sergio Guerrero, MD SBMF President, Joao Massud Filho, MD Vice-President Gustavo Kesselring, MD Treasurer Charles Schmidt, MD.  OTHER DIA EVENTS Overview Walk away from this course being able to produce a defensible schedule, a solid staffing plan, a well-thought-through budget, and a practical risk response plan applicable in the biotechnology, pharmaceutical, and medical product world. Learning Objectives Participants who complete this course should be able to: Describe the five project management process groups: initiating, planning, executing, monitoring and controlling, and closing the project Apply practical project management best practices Recognize and apply project management tools and techniques to the part of the industry in which you are engaged Discuss how to motivate your team; even if it is virtual What You Will Learn Initiating projects Planning projects Executing and controlling projects Risk management Project team dynamics Closing projects Who Should Attend New and experienced project managers Clinical project managers Project practitioners Operational managers Developmental project managers Chemistry, Manufacturing and Control project managers CRAs and LCRAS looking to improve their careers DIA is a  nonprofit charitable and educational association, tax exempt in the United States under Section 501(c)(3) of the Internal Revenue Code, whose purposes are to share information that optimizes the process of drug development and lifecycle management by providing global and regional forums for the exchange of information, education, and training and extensive multidisciplinary networking opportunities. SBMF is a non-profit organization and its mission is the promotion of knowledge and skills for those who work with Pharmaceutical Medicine providing scientific and correct use information for healthcare products, for the benefit of patients and society. For Further Information please contact: In Sao Paulo: Dr. Charles Schmidt, Treasurer, SBMF charles.schmidt@eurotrials.com In Washington DC: Alejandro Bermudez-Del-Villar, M.A. Alejandro.Bermudez@diahome.org  Latin America & Global Program Development Coordinator 1000 Connecticut Avenue, NW Suite 900 Washington, D.C., 20036 USA  Read More Email Preferences    |    My DIA    |    Forward to a Friend    |